KALA BIO, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
KALA BIO, INC. (KALA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $327.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-11-19
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $327.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $379.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $434.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $493.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-09-30 | $327.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $379.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $434.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $493.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $555.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $618.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $685.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $755.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $827.00K 10-Q · filed 2023-11-13 |
| 2019-09-30 | $22.60M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $23.34M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $24.07M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |